NCT01963052 2024-11-01ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial CancerAstellas Pharma IncPhase 1 Completed93 enrolled
NCT02826564 2024-07-17Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial CancerUniversity Hospital, GhentPhase 1 Completed18 enrolled